adenosine diphosphate has been researched along with Cardiovascular Diseases in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (7.89) | 18.7374 |
1990's | 8 (10.53) | 18.2507 |
2000's | 29 (38.16) | 29.6817 |
2010's | 27 (35.53) | 24.3611 |
2020's | 6 (7.89) | 2.80 |
Authors | Studies |
---|---|
Hu, X; Liu, C; Zhang, M; Zhang, W | 1 |
Lai, W; Liu, Y; Shen, Y; Wan, R; Zhang, D | 1 |
Chatzigiannis, CM; Gkalpinos, V; Kostagianni, AD; Kostomitsopoulos, N; Papakyriakopoulou, P; Tellis, CC; Tselepis, AD; Tsiailanis, AD; Tzakos, AG; Valsami, G | 1 |
Bachschmid, MM; Baka, T; Balschi, JA; Colucci, WS; Croteau, D; He, H; Luptak, I; Panagia, M; Pimentel, DR | 1 |
Gager, GM; Hengstenberg, C; Jilma, B; Kolesnik, E; Lang, IM; Prüller, F; Siller-Matula, JM; Toma, A; von Lewinski, D; Wallner, M; Winter, MP | 1 |
Bonello, L; Frere, C; Laine, M | 1 |
Just, SA; Nielsen, C; Nielsen, CB; Nybo, M; Vinholt, PJ | 1 |
Chen, J; Chen, SY; Lian, JJ; Luo, TC; Zeng, XQ | 1 |
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Seidinger, D; Steiner, S | 4 |
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Steiner, S; Xhelili, E | 1 |
Galuszka, J; Hlusi, A; Hutyra, M; Indrak, K; Indrakova, J; Krcova, V; Slavik, L; Ulehlova, J | 1 |
Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S | 1 |
Andrenacci, E; Biscaglia, S; Campo, G; Ferrari, R; Ferri, A; Pavasini, R; Tebaldi, M | 1 |
Bradfield, PF; Chanson, M; Denis, JF; Fontana, P; Imhof, BA; Kwak, BR; Laird, DW; Meens, MJ; Molica, F; Monyer, H; Morel, S; Penuela, S; Zufferey, A | 1 |
Cattaneo, M | 1 |
Hoffmann, K; von Kügelgen, I | 1 |
Agu, RU; Kolathuru, SS; Yeung, PK | 1 |
Aslam, A; Boland, J; Connor, DE; Jarvis, S; Joseph, JE; Low, J; Ly, K; Muller, DW | 1 |
Abdalla, FH; Bagatini, MD; Baldissarelli, J; Cardoso, AM; Dalenogare, DP; Dos Santos, DL; Martins, CC; Morsch, VM; Schetinger, MR; Zanini, D | 1 |
Anstrom, KJ; Baker, BA; Cohen, DJ; Effron, MB; Henry, TD; McCoy, LA; Messenger, JC; Peterson, ED; Wang, TY; Zettler, ME | 1 |
Becker, DM; Becker, LC; Boerwinkle, E; Brody, JA; Chen, MH; Cupples, LA; Eicher, JD; Faraday, N; Gibbs, RA; Johnson, AD; Lin, H; Mathias, RA; Metcalf, GA; Muzny, DM; Pitsillides, AN; Veeraraghavan, N; Yanek, LR | 1 |
Dieplinger, B; Haltmayer, M; Mueller, T; Poelz, W | 1 |
Campbell, CL; Oestreich, JH; Smyth, SS | 1 |
Fox, SC; Heptinstall, S; May, JA; Neubert, U; Shah, A | 1 |
Gluckman, TJ; Jani, JT; Kickler, TS; Laws, K; Nazarian, SM; Rade, JJ; Thompson, JB | 1 |
Abraham, D; Burg, MM; Chaplin, W; Kuruvilla, S; Shimbo, D; Wasson, LT | 1 |
Chen, Q; Cui, B; Ferro, A; Han, Y; Huang, Y; Ji, Y; Jiang, Q; Liu, N; Liu, Y; Mi, Q; Wang, L; Wu, Y | 1 |
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giglioli, C; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Valente, S | 1 |
Bernlochner, I; Braun, S; Jaitner, J; Kastrati, A; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Steinhubl, S; von Beckerath, N | 1 |
Bartko, J; Firbas, C; Jilma, B; Schuetz, M; Schwameis, M; Siller-Matula, J; Spiel, AO; Weigl, M | 1 |
Kameda, S; Kokubo, Y; Mitsuguro, M; Miyata, T; Okamoto, A; Sakata, T; Sano, M | 1 |
Carolei, A; Ciancarelli, I; De Amicis, D; Di Massimo, C; Tozzi Ciancarelli, MG | 1 |
Behr, T; Behr, W; Kuch, B; von Scheidt, W | 1 |
Combescure, C; de Moerloose, P; Fontana, P; Reny, JL; Sanchez, JC; Zufferey, A | 1 |
Boĭchenko, ES; Dubinskaia, RÉ; Khoseva, EN; Kiseleva, NV; Lukina, IuV; Martsevich, SIu; Tolpygina, SN; Voronina, VP | 1 |
Chen, W; McEwen, BJ; Morel-Kopp, MC; Tofler, GH; Ward, CM | 1 |
Condren, R; Dinan, T; Hillmann, A; Kenny, D; Ryan, M; Thakore, JH; Walsh, MT | 1 |
Bhatt, DL; Topol, EJ | 1 |
Buyukkececi, F; Dereli, D; Guney, E; Ozgen, G; Yilmaz, C | 1 |
Bhatt, DL; Jneid, H | 1 |
Kelly, AB; Levy, JH; Szlam, F; Tanaka, KA; Vega, JD | 1 |
Kroner, C; Rechner, AR | 1 |
Ault, KA; D'Agostino, RB; Levy, D; Lipinska, I; Massaro, JM; Mittleman, MA; Mukamal, KJ; Sutherland, PA; Tofler, GH | 1 |
Becker, DM; Becker, LC; Bray, PF; Faraday, N; Herrera-Galeano, JE; Moy, TF; Segal, J; Vaidya, D; Yanek, LR | 1 |
Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
Hawley, JA; Spargo, FJ | 1 |
Fitzgerald, DJ; Maree, AO | 1 |
Akkerman, JW; de Lange, DW; Gorter, G; Kraaijenhagen, RJ; van de Wiel, A; Verhoef, S | 1 |
Alekseev, AE; Hodgson-Zingman, DM; Terzic, A; Zingman, LV | 1 |
Boyer, JL; Crean, C; Durham, T; Fox, AW; Johnson, FL; Kellerman, DJ; Krishnamoorthy, R; Leese, PT | 1 |
Christie, DJ; Gorman, RT; Kottke-Marchant, K | 1 |
Ardo, J; Motovska, Z; Skrakova, M; Sujanova, Z; Widimsky, P; Wimmerova, S | 1 |
Alfonso, F; Angiolillo, DJ | 1 |
Dörner, A; Schultheiss, HP | 1 |
Bestehorn, HP; Büttner, HJ; Frundi, D; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM | 1 |
Engelhardt, A; Lask, S; Mügge, A; Neubauer, H | 1 |
Buring, JE; Hennekens, CH; Lipinska, I; Ridker, PM; Tofler, GH | 1 |
Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N | 1 |
Puri, RN | 1 |
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Muller, JE; Myers, RH; O'Donnell, CJ; Rao, VS; Schmitz, C; Silbershatz, H; Sutherland, PA; Tofler, GH | 1 |
Agteresch, HJ; Dagnelie, PC; van den Berg, JW; Wilson, JH | 1 |
Fitzgerald, DJ; Quinn, MJ | 1 |
Levine, S; Mancini, D; McCully, K | 1 |
Afanasjeva, G; Avdonin, P; Baskova, I; Berezhnoy, S; Gabbasov, Z; Popov, E; Zavalova, L | 1 |
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Mittleman, M; Muller, JE; O'Donnell, CJ; Sutherland, PA; Tofler, GH | 1 |
Jobin, F | 1 |
Heine, H; Heinemann, L; Norden, C; Stepanauskas, M | 1 |
Didisheim, P; Kobayashi, I; Yamazaki, H | 1 |
Cohn, PF; Erikssen, J; Sandvik, L; Stormorken, H; Thaulow, E | 1 |
Aron, L; Hertzeanu, H; Platsker, J | 1 |
Erney, TP; Mathien, GM; Ogilvie, RW; Terjung, RL | 1 |
Hoak, JC; Wu, KK | 1 |
14 review(s) available for adenosine diphosphate and Cardiovascular Diseases
Article | Year |
---|---|
Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic review.
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Resistance; Gastrointestinal Diseases; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Receptors, Purinergic P2Y12; Ticlopidine | 2013 |
P2Y12 receptors: structure and function.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cardiovascular Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Protein Conformation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Structure-Activity Relationship | 2015 |
Pharmacology and structure of P2Y receptors.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Cardiovascular Diseases; Humans; Microglia; Neurodegenerative Diseases; Neurons; Platelet Aggregation; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Uridine Triphosphate | 2016 |
Scientific and therapeutic advances in antiplatelet therapy.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Cardiovascular Diseases; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Single Nucleotide | 2003 |
Advances in antiplatelet therapy.
Topics: Adenosine Diphosphate; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane A2 | 2003 |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure | 2007 |
ATP-sensitive potassium channels: metabolic sensing and cardioprotection.
Topics: Action Potentials; Adenosine Diphosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Cardiovascular Diseases; Diffusion; Energy Metabolism; Homeostasis; Humans; Ion Channel Gating; KATP Channels; Models, Cardiovascular; Myocardium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Signal Transduction; Sulfonylurea Receptors | 2007 |
Adenine nucleotide translocase in the focus of cardiovascular diseases.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Cardiovascular Diseases; Gene Expression; Humans; Mitochondrial ADP, ATP Translocases; Myocardial Ischemia; Myocardium; Oxidative Phosphorylation | 2007 |
Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms.
Topics: Adenosine Diphosphate; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Hemostasis; Humans; Phospholipases A; Phospholipases A2; Platelet Activation; Thrombin | 1998 |
Adenosine triphosphate: established and potential clinical applications.
Topics: Adenosine Diphosphate; Anesthesia; Animals; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Lung Diseases; Neoplasms | 1999 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine | 1999 |
Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cardiovascular Diseases; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Muscle, Skeletal; Phosphocreatine; Phosphorus; Respiratory Physiological Phenomena; Respiratory Tract Diseases | 1999 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
[Prostaglandins in the cardio-vascular system].
Topics: Adenosine Diphosphate; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Cyclic AMP; Cytochrome P-450 Enzyme System; Epoprostenol; Humans; Intramolecular Oxidoreductases; Prostaglandins; Thromboxane A2 | 1985 |
11 trial(s) available for adenosine diphosphate and Cardiovascular Diseases
Article | Year |
---|---|
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study.
Topics: Adenosine Diphosphate; Aged; Capsules; Cardiovascular Diseases; Chemistry, Pharmaceutical; Double-Blind Method; Female; Glucosides; Humans; Male; Middle Aged; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Treatment Outcome | 2015 |
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reproducibility of Results; Sensitivity and Specificity; Stents; Ticlopidine | 2009 |
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial.
Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Blood Platelets; Cardiovascular Diseases; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; P-Selectin; Peptide Fragments; Platelet Aggregation; Recombinant Proteins; Ristocetin; Sex Factors; Thrombosis | 2011 |
Moderate consumption of red wine and human platelet responsiveness.
Topics: Adenosine Diphosphate; Adult; Alcohol Drinking; Blood Platelets; Cardiovascular Diseases; Collagen; Humans; Male; Oxidative Stress; Platelet Aggregation; Platelet Count; Wine; Young Adult | 2011 |
[Comparative evaluation of antiplatelet efectiveness drugs of original and reproduced enteric forms of acetylsalicylic acid (clinical study ICAR))].
Topics: Adenosine Diphosphate; Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Dosage Forms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Therapeutic Equivalency; Treatment Outcome | 2012 |
Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Blood Platelets; Cardiovascular Diseases; Dietary Supplements; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Eicosapentaenoic Acid; Epinephrine; Fatty Acids, Omega-3; Humans; Middle Aged; Platelet Activation; Platelet Aggregation; Young Adult | 2013 |
Sex differences in platelet reactivity and response to low-dose aspirin therapy.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Collagen; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Regression Analysis; Sex Factors | 2006 |
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adolescent; Adult; Bleeding Time; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Double-Blind Method; Female; Hemostasis; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12 | 2007 |
Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Case-Control Studies; Cations; Drug Resistance; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Propyl Gallate; Sensitivity and Specificity | 2007 |
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrroles; Simvastatin; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Topics: Adenosine Diphosphate; Administration, Oral; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Double-Blind Method; Drug Administration Schedule; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Radioimmunoassay; Risk Factors; Thromboxanes | 1996 |
51 other study(ies) available for adenosine diphosphate and Cardiovascular Diseases
Article | Year |
---|---|
Impact of the
Topics: Adenosine Diphosphate; Aspirin; Cardiovascular Diseases; China; Clopidogrel; Humans; Hyperglycemia; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Cell Surface | 2022 |
Chaperone-mediated autophagy attenuates H
Topics: Adenosine Diphosphate; Apoptosis; Autophagy; Cardiovascular Diseases; Chaperone-Mediated Autophagy; Humans; Hydrogen Peroxide; Lysosomal Membrane Proteins; Lysosomes; Myocytes, Cardiac; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen.
Topics: Adenosine Diphosphate; Animals; Apigenin; Arachidonic Acid; Cardiovascular Diseases; Fibrinolytic Agents; Mice; Mice, Inbred C57BL; Olive Oil; Platelet Aggregation; Platelet Aggregation Inhibitors | 2023 |
Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Butyrates; Cardiovascular Diseases; Energy Metabolism; Hemodynamics; Hydrolysis; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Thermodynamics | 2020 |
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prognosis; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Stroke; Survival Rate; Ticagrelor | 2020 |
To Have and Have Not: Intrinsic Platelet Hyperreactivity?
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Humans; Longitudinal Studies; Ticlopidine | 2018 |
The in vitro effect of antirheumatic drugs on platelet function.
Topics: Adalimumab; Adenosine Diphosphate; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Platelets; Cardiovascular Diseases; Collagen; Crotonates; Flow Cytometry; Humans; Hydroxybutyrates; In Vitro Techniques; Nitriles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prednisolone; Risk Factors; Toluidines | 2020 |
Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
Topics: Adenosine Diphosphate; Aged; Angioplasty; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Female; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Peptide Fragments; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Thrombin; Ticlopidine | 2013 |
Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
Topics: Adenosine Diphosphate; Aged; Angioplasty; Angioplasty, Balloon, Coronary; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Stents; Ticlopidine | 2014 |
Detection of clopidogrel resistance using ADP induced aggregometry with specific inhibitor PGE1.
Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Cardiovascular Diseases; Clopidogrel; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Ticlopidine; Treatment Outcome | 2014 |
Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis.
Topics: Adenosine Diphosphate; Aged; Animals; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Female; Flow Cytometry; Humans; Integrin beta3; Leukocytes; Male; Mice; Middle Aged; Oligopeptides; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Sex Factors | 2014 |
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adolescent; Adult; Alleles; Amino Acid Substitution; Animals; Arachidonic Acid; Cardiovascular Diseases; Collagen; Connexins; Gene Frequency; Genotype; Humans; Male; Mefloquine; Mice, Knockout; Nerve Tissue Proteins; Peptide Fragments; Platelet Aggregation; Polymorphism, Single Nucleotide; Probenecid; Purinergic P2X Receptor Antagonists; Recombinant Fusion Proteins; Signal Transduction; Transfection; Young Adult | 2015 |
Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-'Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypoxanthine; Isoproterenol; Rats; Rats, Sprague-Dawley; Uric Acid | 2016 |
Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Extracellular Vesicles; Humans; Middle Aged; Phospholipids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Tartrate-Resistant Acid Phosphatase | 2016 |
Exercise Training positively modulates the Ectonucleotidase Enzymes in Lymphocytes of Metabolic Syndrome Patients.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Cardiovascular Diseases; Exercise; Female; Humans; Lymphocytes; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Time Factors | 2016 |
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after
Topics: Adenosine; Adenosine Diphosphate; Aged; Cardiovascular Diseases; Clopidogrel; Drug Substitution; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Patient Preference; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P1 Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Alleles; Blood Platelets; Cardiovascular Diseases; Cell Adhesion Molecules; Cohort Studies; Epinephrine; Exome; Exome Sequencing; Female; Genotype; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; Male; Massachusetts; Membrane Proteins; Middle Aged; Mutation; Phosphoproteins; Platelet Aggregation; Polymorphism, Genetic; Population Groups; Protein Transport | 2017 |
Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Collagen; Electric Impedance; Epinephrine; Female; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Activation; Platelet Function Tests; Sensitivity and Specificity; Ticlopidine | 2009 |
Platelet function analysis: at the edge of meaning.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Humans; Microfilament Proteins; Patient Selection; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reproducibility of Results; Stents; Ticlopidine | 2009 |
Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Drug Monitoring; Female; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Tissue Fixation | 2009 |
Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy.
Topics: Adenosine Diphosphate; Aspirin; Biomarkers; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Collagen; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies | 2010 |
Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.
Topics: Adenosine Diphosphate; Aggression; Blood Platelets; Cardiovascular Diseases; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Female; Hostility; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Count; Risk Factors | 2009 |
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine | 2010 |
Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
Topics: Adenosine Diphosphate; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon; Blood Platelets; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Female; Humans; Linear Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stents; Ticlopidine | 2010 |
Pyridoxine increases nitric oxide biosynthesis in human platelets.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cardiovascular Diseases; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Pyridoxine; Thrombin; Young Adult | 2009 |
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arachidonic Acid; Cardiovascular Diseases; Chi-Square Distribution; Collagen; Drug Resistance; Drug Therapy, Combination; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome | 2010 |
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinogen; Germany; Humans; Inflammation Mediators; Leukocyte Count; Linear Models; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Association of platelet aggregation with lipid levels in the Japanese population: the Suita study.
Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Collagen; Female; Humans; Japan; Lipids; Male; Middle Aged; Platelet Aggregation | 2011 |
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Drug Monitoring; Drug Resistance; Drug Substitution; Electrodes; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cardiovascular Diseases; Epinephrine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Activation; Platelet Function Tests; Practice Guidelines as Topic; Proteomics; Severity of Illness Index | 2011 |
Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients.
Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Antigens, Surface; Cardiovascular Diseases; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Risk Factors; Schizophrenia, Paranoid; Tetraspanin 30 | 2002 |
Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity.
Topics: Adenosine Diphosphate; Adrenal Hyperplasia, Congenital; Adult; Androgens; Blood Platelet Disorders; Blood Platelets; Cardiovascular Diseases; Collagen; Epinephrine; Female; Humans; Insulin Resistance; Platelet Aggregation; Polycystic Ovary Syndrome | 2003 |
Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
Topics: Adenosine; Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Postoperative Hemorrhage; Purinergic P2 Receptor Antagonists; Retrospective Studies; Thrombelastography; Ticlopidine; Time Factors | 2004 |
Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function.
Topics: Adenosine Diphosphate; Anthocyanins; Cardiovascular Diseases; Collagen; Colon; Diet Therapy; Drug Synergism; Epinephrine; Flavonoids; Humans; Hydrogen Peroxide; Phenols; Platelet Activation; Polyphenols; Receptors, Thrombin | 2005 |
Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study.
Topics: Adenosine Diphosphate; Adult; Alcohol Drinking; Cardiovascular Diseases; Collagen; Cross-Sectional Studies; Epinephrine; Female; Genotype; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Prospective Studies; Risk Factors; Sex Characteristics; Smoking | 2005 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
It's all in the genes, so pick your parents wisely.
Topics: Adenosine Diphosphate; Animals; Cardiovascular Diseases; Mitochondria, Muscle; Muscle, Skeletal; Physical Conditioning, Animal; Physical Endurance; Rats; Risk Factors | 2006 |
Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox.
Topics: Adenosine Diphosphate; Biotransformation; Calcium; Cardiovascular Diseases; Cytosol; Flavonoids; France; Fruit; Humans; Indicators and Reagents; Phenols; Phosphorylation; Plant Extracts; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Polyphenols; Receptors, Thrombin; Tyrosine; Vitis; Wine | 2007 |
Molecule of the month. Ticagrelor.
Topics: Adenosine; Adenosine Diphosphate; Cardiovascular Diseases; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Ticagrelor | 2007 |
Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Collagen; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 2008 |
Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure.
Topics: Adenosine Diphosphate; Cardiovascular Diseases; Clopidogrel; Flow Cytometry; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prognosis; Pyridines; ROC Curve; Sensitivity and Specificity; Ticlopidine; Treatment Outcome | 2007 |
How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
Topics: Adenosine Diphosphate; Aged; Algorithms; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Cardiovascular Diseases; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Resistance; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Ticlopidine | 2008 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles | 1998 |
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study.
Topics: Adenosine Diphosphate; Analysis of Variance; Antigens, Human Platelet; Cardiovascular Diseases; Demography; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Statistics, Nonparametric | 1999 |
Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cardiovascular Diseases; Collagen; Dose-Response Relationship, Drug; Endopeptidases; Fibrinolytic Agents; Humans; Leeches; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 2000 |
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
Topics: Adenosine Diphosphate; Alleles; Antigens, Human Platelet; Cardiovascular Diseases; Epinephrine; Epitopes; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Vasoconstrictor Agents; von Willebrand Factor | 2001 |
[Prevention of cardiovascular complications in manifest arteriosclerosis by the use of Micristine].
Topics: Adenosine Diphosphate; Anticoagulants; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Humans; Platelet Aggregation | 1979 |
Cardiopulmonary dysfunctions caused by ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Pressure; Bradycardia; Busulfan; Cardiovascular Diseases; Heart Rate; Injections, Intra-Arterial; Injections, Intravenous; Male; Oxygen; Platelet Adhesiveness; Platelet Aggregation; Rats; Respiration; Respiratory Insufficiency; Sinoatrial Block; Spleen; Splenectomy; Time Factors | 1975 |
Blood platelet count and function are related to total and cardiovascular death in apparently healthy men.
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Electrocardiography; Exercise Test; Humans; Male; Platelet Aggregation; Platelet Count; Prospective Studies; Smoking | 1991 |
Peripheral adaptations to low blood flow in muscle during exercise.
Topics: Adaptation, Physiological; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Capillaries; Cardiovascular Diseases; Extremities; Humans; Mitochondria, Muscle; Muscles; Oxygen Consumption; Physical Exertion; Regional Blood Flow | 1988 |
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.
Topics: Adenosine Diphosphate; Adolescent; Adult; Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Cell Count; Blood Specimen Collection; Cardiovascular Diseases; Formaldehyde; Humans; In Vitro Techniques; Infusions, Parenteral; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Thrombin; Thromboembolism | 1974 |